A full list of publications can be found here.

Key research papers:

  • Combined EZH2 inhibition and Ikaros degradation leads to enhanced anti-tumor activity in diffuse large B-cell lymphoma. Tong K, Yoon S, Isaev K, … Kridel R. Clinical Cancer Research. 2021.
  • A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pre-transplant Deauville score. Yhim HY, Eshet Y, Metser U, Lim CH, … Kuruvilla J, Kridel R. Blood Advances. 2020 Nov 24;4(22):5762-5771.
  • Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma. Calvente L, … Kridel R. Br J Haematol. Sep;190(6):864-868.
  • Molecular Attributes Underlying Central Nervous System and Systemic Relapse in Diffuse Large B-cell Lymphoma. Isaev K, … Scott DW, Kridel R. Haematologica. 2020 Aug 13;haematol.2020.255950.
  • Convergence of risk prediction models in follicular lymphoma. Silva A, … Kridel R. Haematologica. 2019 Jun;104(6):e252-e255.
  • FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab-containing regimens. Mottok A,* Jurinovic V,* … Hoster E,* Weigert O,* Kridel R.* Blood. 2018 Jan 11;131(2):226-235. (* denotes equal contribution)
  • Diffuse large B-cell lymphoma with testicular involvement: Outcome and risk of CNS relapse in the rituximab era. Kridel R*, Telio D*, … Savage KJ. British Journal of Haematology. 2017 Jan;176(2):210-221. (* denotes equal contribution)
  • Histological Transformation and Progression in Follicular Lymphoma: a Clonal Evolution Study. Kridel R*, Chan FC*, Mottok A, … Gascoyne RD, Shah P. PLOS Medicine. 2016 Dec 13;13(12):e1002197. (* denotes equal contribution)
  • Cell of origin of transformed follicular lymphoma. Kridel R,* Mottok A,* … Scott DW, Gascoyne RD. Blood 2015 Oct 29;126(18):2118-27. (* denotes equal contribution)
  • Integration of Gene Mutations Improves Risk Prognostication in Patients Receiving First-line Immunochemotherapy for Follicular Lymphoma in Clinical Trial and Population-Based Cohorts. Pastore A,* Jurinovic V,* Kridel R,* Hoster E,* … Gascoyne RD, Weinstock DM, Weigert O. Lancet Oncol. 2015 Sep;16(9):1111-22. (* denotes equal contribution)
  • The prognostic impact of CD163-positive macrophages in follicular lymphoma: A study from the BC Cancer Agency and the LYmphoma Study Association. Kridel R, Xerri L, … Gascoyne RD, Salles G. Clin Cancer Res. 2015 Aug 1;21(15):3428-35.
  • Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Kridel R, Meissner B, … Weng AP, Steidl C, Gascoyne RD. Plenary Paper. Blood. 2012 Mar 1;119(9):1963-71.

Key review papers:

  • Treatment resistance in diffuse large B-cell lymphoma. He MY, Kridel R. Leukemia. 2021.
  • Predicting early progression in follicular lymphoma. Liu Q, Silva A, Kridel R. Annals of Lymphoma. 2021 Jun;5:11.
  • Pathogenesis of follicular lymphoma. Lackraj T, Goswami R, Kridel R. Best Practice & Research Clinical Haematology. 2018 Mar;31(1):2-14.
  • Can histologic transformation of follicular lymphoma be predicted and prevented? Kridel R, Sehn LH, Gascoyne RD. Blood. 2017 Jul 20;130(3):258-266.
  • Pathogenesis of follicular lymphoma. Kridel R, Sehn LH, Gascoyne RD. J Clin Invest. 2012 Oct 1;122(10):3424-31.
  • Prevention of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma. Kridel R, Dietrich PY. Lancet Oncol. 2011 Dec;12(13):1258-66.